Market news, stock analysis and investing ideas

Enovix Gaps Down 10% Then Falls Further: An Earnings Gap Case Study for ENVX

Enovix gapped down 10.28% at the open on Nov. 12 after results, then fell further to close 28.66% below its Nov. 11 close. The session shows how an earnings gap can extend instead of fill.

Enovix Gaps Down 10% Then Falls Further: An Earnings Gap Case Study for ENVX

Enovix Corporation (NASDAQ: ENVX) filed third-quarter results at 7:44 a.m. ET on Nov. 12, in pre-market trading, showing $11.0 million in revenue and 2027 guidance of $65 million to $85 million, according to its 8-K. The company also dropped smartphone field testing after its AI-1 cells missed an energy-density target. Shares closed at $1.81, down 28.66% from the Nov. 11 close.

A 10% gap down that kept widening

Shares gapped down 10.28% at the open on Nov. 12, then fell another 20.13% during the regular session. The gap did not fill (a return to the prior close); sellers pushed the price well below it. The release carried good and bad items at once, and the price action does not show which one drove the selling.

How an earnings gap works

The regular session runs from 9:30 a.m. to 4 p.m. ET, but companies often report outside those hours. Between the close and the next open, trading continues in thinner pre-market and after-hours sessions, so the next regular session can open well away from the prior close. That difference is the gap.

A gap is the market repricing a whole release at once: results against expectations, guidance (the company's own forecast) and any other disclosure. Pre-market prices come from few trades and are a rough first read. The regular session, with far more volume, shows whether buyers and sellers accept that price. The gap can then fill, hold or extend.

What the Nov. 12 trading showed

Enovix closed at $2.53 on Nov. 11 and rose 0.4% in after-hours trading that evening to $2.54, before the results. On Nov. 12, the last pre-market trade, at 9:29 a.m., was $2.26, down 11.02% from that after-hours close and 10.67% below the Nov. 11 close. The pre-market range ran from $2.10 to $2.63 on 1.32 million shares. It is not clear how much of that range traded before the 8-K.

The regular session pushed lower. Shares dropped 20.13% from the pre-market close and hit a low of $1.79 before closing at $1.81. Volume was 21.88 million shares, against a 10-day average of about 6.92 million a day. That equaled 11.3% of the 193.8 million-share float (the shares available to trade).

In after-hours trading on Nov. 12, shares rose 7.48% to $1.94 on 288,944 shares, still 23.32% below the Nov. 11 close. At 5:32 p.m. ET, law firm Block & Leviton announced an investigation into whether Enovix and its executives misled investors about smartphone qualification progress. The firm said it is seeking to represent investors who bought common stock and lost money.

The days before were volatile. Shares fell 13.98% on Nov. 5 to $2.40, rose 15% on Nov. 6 to $2.76, and closed at $2.78, $2.64 and $2.53 on Nov. 9, 10 and 11. From Oct. 14 to Nov. 11 the stock gained 3.69%, with a high of $3.57 on Oct. 29 and a 25% jump on Oct. 27.

A strong quarter, a missed smartphone target

The company's release looked good on its face. Revenue rose 38% from the third quarter of 2025, the sixth straight quarter of year-over-year growth. Non-GAAP gross margin (which excludes items such as stock compensation) reached a record 34.5%, up 13.5 points. Non-GAAP loss per share was $0.15, against $0.14 a year earlier.

The smartphone news cut the other way. The company said AI-1 cells passed its internal cell-level qualification, but the test used a version made before its AI-2 process and missed the target of more than 1,000 watt-hours per liter. It said its lead phone customer was due to finish its own qualification the following week. Enovix will now focus silicon-anode work on smart eyewear. Block & Leviton said management had earlier described the phone qualification as nearly complete.

Near-term guidance also came in below the quarter just reported. Fourth-quarter sales are guided at $9.0 million to $10.0 million, against $11.0 million in the third quarter, with an adjusted loss of $0.13 to $0.17 per share.

The rest of the release

  • Cash: $512.2 million in cash, securities and restricted cash as of Oct. 4, or $2.35 per outstanding share, before October repurchases of about $81.4 million of notes and $15.5 million of stock.
  • Drones: the pipeline of identified prospects rose to about $216 million from $183 million in the prior quarter. The company reported an initial 100,000-battery order and a first production order for its MX1-B01 aerial drone cell, with deliveries starting in early 2027.
  • 2027 outlook: Interim CEO Ryan Benton said nearly half the midpoint of the $65 million to $85 million range is already in backlog.
  • Costs: a restructuring cut 220 positions and about $8.5 million in annual cost, shifting resources toward Korean operations. A $19 million expansion there is due online in the second quarter of 2027.
  • Debt: the company retired $128.0 million face value of 2030 notes for about $81.4 million, a 36% discount. The remaining 2030 notes stand at $232.0 million, and a warrant dividend is meant to retire the 2028 notes.
  • Smart eyewear: about 19,000 units had shipped this year against a 50,000-pack backlog due to finish in the first half of 2027.

What comes next

  • The lead phone customer's own qualification result, which the company expected the week after the Nov. 12 release.
  • Initial MX1-B01 deliveries in early 2027 and the Korean capacity expansion, due in the second quarter of 2027.
  • Fourth-quarter results against the $9.0 million to $10.0 million sales guidance.
  • The company's 10-Q filing and its warrant dividend aimed at the 2028 notes.

Bottom line

Enovix opened 10.28% below its Nov. 11 close on Nov. 12, and the regular session took the stock 28.66% below it, on volume more than three times its 10-day average. The after-hours bounce to $1.94 came on 288,944 shares, thin trading that left the stock 23.32% under the Nov. 11 close.


This article was processed by WSN Finance AI Analysis and prepared by WSN Editors based on financial analysis.

This article is for informational purposes only and is not investment advice.

Read the original report